Mild hyperuricemia induces glomerular hypertension in normal rats

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Sánchez Lozada, Laura G ^a   Tapia, Edilia ^a   Avila Casado, Carmen ^a   Soto, Virgilia ^a   Franco, Martha ^a   Santamaría, José ^a   Nakagawa, Takahiko ^b   Rodríguez Iturbe, Bernardo ^c   Johnson, Richard J ^b   Herrera Acosta, Jaime ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

Author keywords

Arteriolopathy; Hypertension; Micropuncture; Renal hemodynamics; Uric acid

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAPILLARY PRESSURE; CONTROLLED STUDY; GLOMERULUS CAPILLARY; HISTOLOGY; HYPERURICEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

EID: 0036839067     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00170.2002     Document Type: Article

References (35)

1. Anderson S, Meyer TW, Rennke HG, and Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985.
2. Beck L. Requiem for gouty nephropathy. Kidney Int 30: 280-287, 1986.
3. Blantz RC, Gabbai FB, Tucker BJ, Yamamoto T, and Wilson CB. Role of the mesangial cell in glomerular response to volume, and angiotensin II. Am J Physiol Renal Fluid Electrolyte Physiol 264: F158-F165, 1993.
4. Blantz RC, Konnen KS, and Tucker BJ. Glomerular filtration response to elevated ureteral pressure in both the hydropenic and the plasma-expanded rat. Circ Res 37: 819-829, 1975.
5. Bobadilla N, Tack I, Tapia E, Sánchez-Lozada LG, Santamaría J, Jiménez F, Striker LJ, Striker GE, and Herrera-Acosta J. Pentosan polysulfate prevents glomerular hypertension and structural injury despite persisting hypertension in 5/6 nephrectomy rats. J Am Soc Nephrol 12: 2080-2087, 2001.
6. Cameron JS, Moro F, McBride M, and Simmonds HA. Inherited disorder of purine metabolism and transport. In: The Oxford Textbook of Clinical Nephrology (1st ed.), edited by Davison A II, Cameron JS, Grünfeld JP, Kerr DS, Ritz E, and Winearls CG. Oxford, UK: Oxford Medical, 1998, p. 2469-2482.
7. Davidson WD and Sackner MA. Simplification of the anthrone method for the determination of inulin clearance studies. J Lab Clin Med 62: 351-356, 1963.
8. Doctor RB and Mandel LJ. Minimal role of xanthine oxidase and oxygen radicals in rat renal tubular reoxygenation injury. J Am Soc Nephrol 1: 959-969, 1991.
9. Gonick HC, Rubini MD, Gleason IO, and Sommers SC. The renal lesion in gout. Ann Intern Med 62: 667-674, 1965.
10. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Sthal RAK, Macharzina R, Bräsen J, Meinertz T, and Miinzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: Evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
11. Herrera-Acosta J, Franco M, Tapia E, Gabbai F, Cermen̄o JL, Calleja C, Pérez JM, Barrios R, and Torres G. Mechanism of glomerular permeability reduction in non-clipped kidney of rats with Goldblatt hypertension. Hypertension 8, Suppl I: I-105-I-109, 1986.
12. Herrera-Acosta J, Tapia E, Bobadilla NA, Romero L, Cermen̄o JL, Alvarado JA, and Gabbai FG. Evaluating hyperfiltration with glycine in hypertensive rats with renal ablation. Hypertension 11, Suppl I: 33-37, 1998.
13. Ichikawa I, Yoshida Y, Fogo A, Purkerson ML, and Klahr S. Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34: 638-644, 1988.
14. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, and Takashita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24: 691-697, 2001.
15. Joannidis M, Gstraunthaler G, and Pfaller W. Xanthine oxidase: Evidence against a causative role in renal reperfusion injury. Am J Physiol Renal Fluid Electrolyte Physiol 258: F232-F236, 1990.
16. Johnson RJ, Kivlighn SD, Kim YG, Suga S, and Fogo A. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33: 225-234, 1999.
17. Katoh T, Takahashi K, Klahr S, Reyes AA, and Badr KF. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 4: 1690-1694, 1994.
18. Lax DS, Benstein JA, Tolbert E, and Dworkin LD. Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 41: 1527-1534, 1992.
19. Mazzali M, Feng L, Kang DH, Watanabe S, Kanellis J, Nakawaga T, Lan HY, and Johnson RJ. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282: F991-F997, 2002.
20. Mazzali M, Hughes J, Kim YG, Jefferson J, Kang DH, Gordon KL, Lan HY, Kivlighn S, and Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001.
21. Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlingh SD, Lan HY, and Johnson RJ. Hyperuricemia exacerbates chronic cyclosporin nephropathy. Transplantation 71: 900-905, 2001.
22. Morsing P, Stenberg A, Müller-Suur C, and Persson EG. Tubuloglomerular feedback in animals with unilateral, partial ureteral occlusion. Kidney Int 32: 212-218, 1987.
23. Nickeleit V and Mihatsch MJ. Uric acid nephropathy and end stage renal disease: Review of a non-disease. Nephrol Dial Transplant 12: 1832-1838, 1997.
24. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, and Hikita M. Serum uric acid and renal prognosis in IgA nephropathy. Nephron 83: 333-339, 2001.
25. Oliva H and Barat A. Histopathology of the kidney in percutaneous biopsy in gout. In: The Kidney in Gout and Hyperuricemia (1st ed.), edited by Yü T and Berger L. Mount Kisco, NY: Futura, 1982, p. 175-194.
26. Pawelczk T, Bizon D, and Angielski S. The distribution of enzymes involved in purine metabolism in rat kidney. Biochim Biophys Acta 1116: 309-314, 1992.
27. Rao GN, Corson MA, and Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266: 8604-8608, 1991.
28. Schor N, Ichikawa I, and Brenner BM. Glomerular adaptations to chronic dietary salt restriction or excess. Am J Physiol Renal Fluid Electrolyte Physiol 238: F428-F436, 1980.
29. Syrjiinen J, Mustonen J, and Pasternak A. Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15: 34-42, 2000.
30. Talbott JH and Terplan KL. The kidney in gout. Medicine 39: 405-467, 1960.
31. Tapia E, Gabbai FG, Calleja C, Franco M, Cermen̄o JL, Bobadilla NA, Pérez JM, Alvarado JA, and Herrera-Acosta J. Determinants of renal damage in rats with systemic hypertension and partial renal ablation. Kidney Int 38: 642-648, 1990.
32. Viets JW, Deen WM, Troy JL, and Brenner BM. Determination of serum protein concentration in nanoliter blood samples using fluorescamine or o-phthaldehyde. Anal Biochem 88: 513-521, 1978.
33. Vurek GG and Pegram SE. Fluorometric method for the determination of nanogram quantities of inulin. Anal Biochem 16: 409-419, 1966.
34. Wahlberg J. The renal response to ureteral obstruction. Scand J Urol Nephrol Suppl 73: 1-30, 1983.
35. Zou AP, Li N, and Cowley AW. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.